Changes of peripheral α-melanocyte–stimulating hormone in childhood obesity
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Relationships of blood circulating melanocortins to childhood obesity are not well established. We evaluated serum α-melanocyte–stimulating hormone (α-MSH) in lean children and different study groups of childhood obesity. We examined serum α-MSH in 52 otherwise healthy children with childhood obesity (Ob; mean age, 11 years; 32 girls/20 boys), 27 normal-weight children of same age, 7 additional obese patients with reduced melanocortin-4 receptor function (MC4Rmut), and 22 patients with craniopharyngioma (CP). Fasting serum α-MSH and leptin were measured by radioimmunoassay. Serum α-MSH was also evaluated 1 hour after 500-kcal liquid meal (CP and Ob) and at the end of 1-year lifestyle intervention in 24 Ob patients. The α-MSH levels were similar in obese vs lean children but significantly lower in CP (P< .001) and significantly higher (P < .05) in MC4Rmut patients compared with Ob. One hour after liquid meal, α-MSH increased in patients with Ob but not with CP. After 1 year, α-MSH levels increased significantly in the successful weight reduction Ob subgroup despite unchanged cortisol levels. The α-MSH changes correlated to weight status changes (r = 0.67, P = .0003) but not to changes of cortisol, insulin, or homeostasis model assessment of insulin resistance index. Persistently low α-MSH levels in CP patients are suspected to be due to pituitary or hypothalamic damage. High peripheral levels in MC4Rmut carriers indicate up-regulation of α-MSH. Changes of weight status are associated with changes of peripheral α-MSH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Studies on the Physiological Functions of the Melanocortin System
Cone, R. D. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0034 · Cited by 615 · cited 1×
“Although considered to be primarily of pituitary origin, small quantities of these proopiomelanocortin (POMC)derived peptides have been identified in a variety of peripheral tissues such as the thyroid, pancreas, and gastrointestinal tract [1-3].”
BackgroundRossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.6332 · Cited by 576 · cited 1×
“Besides the central appetite-suppressing (anorexigenic) effect of α-MSH [14], melanocortins increase the metabolic rate mediated by peripheral cells expressing different melanocortin receptors such as muscle cells, expressing MC1R, MC3R, MC4R, and especially MC5R [15,16].”
BackgroundKaravitaki, N., Cudlip, S., Adams, C. B. T., & Wass, J. A. H. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0002 · Cited by 514
Lifestyle Intervention in Obese Children With Variations in the Melanocortin 4 Receptor Gene
Reinehr, T., Hebebrand, J., Friedel, S., Toschke, A. M., Brumm, H., Biebermann, H., & Hinney, A. (2009) · Obesity · doi:10.1038/oby.2008.422 · Cited by 166 · cited 1×
“The third group consisted of additional 7 obese patients with identified MC4R mutations entailing a reduced receptor function (group MC4Rmut: 3 girls/4 boys; mean age, 12 years), identified in a cohort of 328 obese children treated in Datteln or in Bonn, who were screened for MC4R mutations (see below for the differen…”
BackgroundSelf-citation
Cited by
Müller, H. L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1115 · Cited by 401
Self-citationRoth, C. L., Scimia, C., Shoemaker, A. H., Gottschalk, M., Miller, J., Yuan, G., Malhotra, S., & Abuzzahab, M. J. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00087-1 · Cited by 76
Self-citationHypothalamic obesity: prologue and promise
Abuzzahab, M. J., Roth, C. L., & Shoemaker, A. H. (2019) · Hormone Research in Paediatrics · doi:10.1159/000496564 · Cited by 71
Self-citationAcquired hypothalamic obesity: A clinical overview and update
Roth, C. L., & McCormack, S. E. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15530 · Cited by 42
“Synthetic MC receptor agonists are promising for the treatment of genetic and surgery-induced HO affecting the MC4R pathway 119 as there is clear evidence that central MC signalling is deficient 8,45,46,65,120,121 in individuals with these conditions.”
BackgroundSelf-citationA Novel Rodent Model That Mimics the Metabolic Sequelae of Obese Craniopharyngioma Patients
Roth, C. L., Blevins, J. E., Ralston, M., Elfers, C., Ogimoto, K., Kaiyala, K. J., & Morton, G. J. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e3182083b67 · Cited by 35
“Moreover, similar to what is observed in obese CP patients (34), CMHL rats exhibited a selective reduction in plasma -MSH levels relative to the other groups, and were also characterized by reduced locomotor activity, even after adjusting for differences in body size.”
Self-citation
Metadata
- Authors
- Roth, C. L., Enriori, P. J., Gebhardt, U., Hinney, A., Müller, H. L., Hebebrand, J., Reinehr, T., & Cowley, M. A.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 59
- Issue
- 2
- Pages
- 186-194
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2008849044
- Cited by
- 56
- References
- 6
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes of peripheral α-melanocyte–stimulating hormone in childhood obesity. https://app.cochat.ai/papers/10.1016/j.metabol.2009.06.031
- The paper
- Roth, C. L., Enriori, P. J., Gebhardt, U., Hinney, A., Müller, H. L., Hebebrand, J., Reinehr, T., & Cowley, M. A. (2010). Changes of peripheral α-melanocyte–stimulating hormone in childhood obesity. Metabolism. https://doi.org/10.1016/j.metabol.2009.06.031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.